Member Exclusive

Developing a bioanalytical assay for stromal cell therapies: an interview with Laura Deedigan, Orbsen Therapeutics

In this interview, Laura Deedigan (Orbsen Therapeutics) discusses the challenges in characterizing the purity of MSCs and why this is in important in cellular therapies.

Go to the profile of RegMedNet
Apr 24, 2018

Please sign in or register for FREE

No comments yet.